|
Harrison Clinical
Research is an independent CRO founded in 1987. It is involved in
the clinical development and registration of new pharmaceutical
products and medical devices from Phase I, in our own clinics in
Germany and Israel, through to Phase IV, throughout Europe, Scandinavia,
Israel and the countries of Eastern Europe. HCR has an excellent
reputation in running Phase I and early Phase II studies, in it's
clinics, in a multitude of indications. HCR offers a multinational
service and has established offices in Germany, UK, Benelux, Israel,
Spain, Italy and France and works together with a network of investigators
and centers across Europe. HCR undertakes total clinical development
of products to meet all local and international standards and was
awarded the ISO 9001 certification in March 1998, for quality management
in clinical research. HCR will help VDDI form business relationships,
with a major thrust towards biotechnology products. In addition,
HCR will function as an outpost for the global document and study
report generation program using shareware and web based technology.
| SFBC
provides a full range of clinical pharmacology services for
short-term studies, as well as the most complex long-term Phase
I-Phase IV studies including: protocol design, data management,
electronic data transfer, Report writing, IRB, clinical/analytical
services, and clinical monitoring services. SFBC is a five-floor,
free-standing modern facility designed for optimum efficiency
and confidentiality. The Phase I-IV inpatient and outpatient
services are supported by a screening and outpatient team, recruiting,
integrated internal QA/QC, and easily accessible IRB. Length
of studies range from 12 hours to 70 days of confinement. It
is anticipated that many of the US Phase I and Phase II studies
will be conducted at SFBC. |
Go
Page 1 of 2
Site
created and maintained by Opposable
Thumb Digital.
|
